The cardiovascular needle market was valued at USD 105.6 million in 2025, is projected to reach USD 222.3 million by 2036 and is forecast to register a 7.0% CAGR between 2026 and 2036. In 2026, round bodied needles hold 57.3% of product sales and coronary artery bypass graft surgery represents 34.9% within the application segment.